Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency

被引：0

作者：

Naoko Miyata

Mitsuhiro Isaka

Hideaki Kojima

Tomohiro Maniwa

Shoji Takahashi

Osamu Takamiya

Yasuhisa Ohde

机构：

[1] Shizuoka Cancer Center,Division of Thoracic Surgery

[2] Nagahama Institute of Bio-Science and Technology,Department of Bioscience, Faculty of Bioscience

来源：

General Thoracic and Cardiovascular Surgery | 2016年 / 64卷

关键词：

Inherited factor VII deficiency; Continuous infusion; Recombinant activated factor VII; Lobectomy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Inherited factor VII (FVII) deficiency is a rare recessive inherited coagulation disorder with limited available information, especially in patients undergoing major thoracic surgery. In addition, an optimal management strategy for the disease has not been defined. We herein report a case involving a 61-year-old man with asymptomatic FVII deficiency who underwent a right middle and lower lobectomy to treat lung cancer. To the best of our knowledge, the present report is the first to describe the use of recombinant activated FVII continuous infusion for bleeding control after a major thoracic surgery in a patient with inherited FVII deficiency.

引用

页码：177 / 180

页数：3

共 50 条

[41] Vena porta thrombosis in patient with inherited factor VII deficiency
Klovaite, Jolanta
Friis-Hansen, Lennart
Larsen, Fin S.
Toffner-Clausen, Nielsaage
Bjerrum, Ole W.
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 285 - 288
[42] TREATMENT TACTICS FOR A PATIENT WITH ACQUIRED HEMOPHILIA: CONTINUOUS INFUSION OF RECOMBINANT ACTIVATED COAGULATION FACTOR VII AND THE INHIBITOR ERADICATION
Galstyan, G. M.
Nalbandyan, S. A.
Sabirov, K. R.
Soboleva, O. A.
Kovalenko, A., V
Gorgidze, L. A.
Zorenko, V. Y.
[J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2022, 67 (02): : 282 - 294
[43] Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII - Plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding
Smith, MP
Ludlam, CA
Collins, PW
Hay, CRM
Wilde, JT
Grigeri, A
Melsen, T
Savidge, GF
[J]. THROMBOSIS AND HAEMOSTASIS, 2001, 86 (04) : 949 - 953
[44] Successful treatment of a patient with a severely bleeding peptic ulcer with recombinant activated factor VII
Vlot, AJ
Ton, E
Mackaay, AJC
Kramer, MHH
Gaillard, CAJM
[J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 96 - 96
[45] Successful treatment of massive bleeding in an obstetric patient using recombinant activated factor VII
Rivas-Valenzuela, E
Rangel, EF
Perez-Rada, FJ
Saucedo, P
Sanchez-Nava, VM
Cedillo-Juarez, J
Perez-Cornejo, S
[J]. CRITICAL CARE MEDICINE, 2005, 33 (12) : A182 - A182
[46] Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII
Vlot, AJ
Ton, E
Mackaay, AJC
Kramer, MHH
Gaillard, CAJM
[J]. AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 421 - 423
[47] THE USE OF RECOMBINANT ACTIVATED FACTOR VII IN A PATIENT WITH UNCONTROLLED BLEEDING FROM THE GASTROINTESTINAL TRACT
Vitkovic, Radomir
Petrovic, Ivan
[J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2008, 136 : 246 - 248
[48] Successful use of recombinant activated factor VII (rFVIIa) perioperative management and outcome of urgent appendectomy in a patient with congenital factor VII deficiency
Soker, M.
Uzel, H.
Oncel, K.
Basuguy, E.
Soker, S.
[J]. HAEMOPHILIA, 2019, 25 : 143 - 144
[49] Repeated recombinant activated factor VII administration in a patient with congenital factor VII deficiency undergoing modified radical hysterectomy: a case report
Shirasawa, H.
Yoshioka, T.
Sawada, K.
Terada, Y.
[J]. HAEMOPHILIA, 2014, 20 (01) : E101 - E103
[50] Recombinant activated factor VII to control massive post operative bleeding after septic aortobifemoral grafting
Raux, M
Chiche, L
Vanhille, E
Riou, B
[J]. EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2005, 22 (10) : 805 - 807

← 1 2 3 4 5 →